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Invasion of vascular endothelial cells is thought to be a critical step in the development of
metastatic infections in patients with Staphylococcus aureus bacteraemia. This study was
designed to evaluate the association between the ability to invade endothelial cells and metastatic
infection by S. aureus. Patients with metastatic infection were identified among those with
community-acquired S. aureus bacteraemia in a tertiary referral hospital. Patients with simple
bacteraemia caused by S. aureus over the same period served as the control group. The ability of
each clinical isolate to invade endothelial cells was evaluated by counting the number of
intracellular organisms 1 h after inoculation onto human umbilical vein endothelial cells in vitro.
The cytotoxic activity of intracellular S. aureus was determined 24 h after internalization, and
expressed as the percentage of cells killed. The clinical isolates varied in invasiveness and
cytotoxicity. The median invasiveness, relative to S. aureus reference strain ATCC 29213, was
145 % in the cases (n510) [interquartile range (IQR) 103–160] and 153 % (IQR 111–173) in
the controls (n511; P50.44). The median cytotoxicity was 59.4 % (IQR 47–68) in the cases
and 65.2 % (IQR 50–74) in the controls (P50.44). Differences in the ability of S. aureus to
invade and destroy vascular endothelial cells in vitro were not associated with the development of
metastatic complications in patients with S. aureus bacteraemia. This implies that the invasiveness
and toxicity of S. aureus for endothelial cells may not be major determinants of metastatic
infection.
INTRODUCTION
Staphylococcus aureus is an important cause of severe
community-acquired and nosocomial bacteraemia
(Weinstein et al., 1997). A major complication of S. aureus
bacteraemia is the development of metastatic infection.
The reported frequency of metastatic infection following S.
aureus bacteraemia varies from 2 to 47 % (Lautenschlager
et al., 1993; Willcox et al., 1998; Mylotte et al., 1987; Nolan
& Beaty, 1976; Cunney et al., 1996; Finkelstein et al., 1984).
The most common sites of metastatic foci include cardiac
valve, bone and joints, lung, kidney, central nervous system
and skin (Lautenschlager et al., 1993; Julander, 1985; Nolan
& Beaty, 1976; Mirimanoff & Glauser, 1982). Metastatic
complications in S. aureus bacteraemia are clinically
important because they are associated with recurrent
infection and grave outcome (Musher et al., 1994;
Lautenschlager et al., 1993; Julander, 1985).
Although little is known about the pathogenesis of
metastatic complications in S. aureus bacteraemia, it is
thought that interaction between vascular endothelial cells
and circulating bacteria is a first step in the extravasation of
S. aureus (Lowy, 1998). Many studies have shown that S.
aureus bacteria attach avidly to and invade vascular
endothelial cells (Vercellotti et al., 1984; Ogawa et al.,
1985). After invasion, the infected endothelial cells express
Fc receptors and adhesion molecules, and then release
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interleukin-1, interleukin-6 and interleukin-8. This
sequence of events facilitates the inflammatory process
and contributes to the establishment of metastatic infection
(Lowy, 1998). However, to the best of our knowledge, no
study has demonstrated the clinical relevance of invasion of
vascular endothelial cells to the development of metastatic
infection in patients with S. aureus bacteraemia.
Internalized S. aureus can either survive for several days in
the cytoplasm (Balwit et al., 1994) or induce the death of
endothelial cells by apoptosis (Menzies & Kourteva, 1998).
Clinical isolates with increased cytotoxic activity produced
higher lethality and more dissemination in a mouse
septicaemia model (Krut et al., 2003). However, the clinical
significance of the cytotoxicity of intracellular S. aureus
remains unclear.
The purpose of the present study was to determine whether
(1) the ability of S. aureus to invade vascular endothelial
cells or (2) the cytotoxicity of intracellular S. aureus for
vascular endothelial cells were determinants of metastatic
infection in patients with S. aureus bacteraemia.
METHODS
Patients with and without metastatic infection. Cases of
metastatic infection were identified among patients with commun-
ity-acquired S. aureus bacteraemia at Seoul National University
Hospital from January 1998 to December 2001. The control group
consisted of patients with community-acquired and simple S. aureus
bacteraemia over the same period.
The portal of entry was defined as the localized focus of S. aureus
infection preceding bacteraemia, and any other foci were considered
to represent metastatic infection (Lautenschlager et al., 1993).
Community-acquired S. aureus bacteraemia was defined as the
presence of a positive blood culture within 48 h of admission. A
simple bacteraemic patient was defined as one with defervescence
within 3 days of the onset of antibiotic treatment, and no evidence of
metastatic complications.
Bacterial storage, growth and harvest. The clinical isolates and
the S. aureus ATCC 29213 reference strain which had been stored in
skimmed milk at 270 uC were subcultured on blood agar. Fresh
colonies were inoculated into brain heart infusion broth and grown
overnight at 37 uC. Two hours before the experiment, overnight
cultures were resuspended in fresh brain heart infusion broth and
grown to mid-exponential phase. The bacteria were collected by
centrifugation, washed three times in PBS, and resuspended in
antibiotic-free EGM-2 medium (Cambrex). The suspensions were
centrifuged at 75 g for 5 min to remove variable-sized aggregates
(Van Belkum et al., 2002), and bacterial concentrations were
measured spectrophotometrically at 620 nm and counted by plating
serial dilutions on agar. Antibiotic susceptibility was determined by
the disc diffusion method, as recommended by the CLSI (2005).
PFGE was performed as described previously (Kim et al., 2006).
Preparation of endothelial cells. Human umbilical vein endothe-
lial cells (HUVECs) were used in these experiments. They were grown
to confluence in 24-well plates at 37 uC in a humidified incubator
with 5 % CO2, in antibiotic-free EGM-2 medium containing 5 %
fetal bovine serum and growth factors. All experiments were
performed with cells that had been passaged between four and eight
times.
Invasion assay. The invasion assay was performed to determine
numbers of internalized bacteria, as described by Ogawa et al. (1985).
Each well containing HUVECs was washed with antibiotic-free EGM-
2 medium prior to inoculation with bacteria. Bacterial suspension
(1 ml), adjusted by optical density to 56107 c.f.u. ml21 (m.o.i. 250),
was added to each well and incubated for 1 h at 37 uC in 5 % CO2.
The complementary study showed that the number of intracellular S.
aureus was linearly correlated with the m.o.i., and that the difference
in invasiveness between isolates was similar irrespective of m.o.i.
under our experimental conditions (data not shown).
The plates were then washed twice with antibiotic-free EGM-2
medium and incubated at 37 uC for 20 min with antibiotic-free
EGM-2 medium, which contained 10 mg lysostaphin ml21 (Sigma) to
lyse extracellular staphylococci. The HUVECs were then released with
trypsin, disrupted in hypotonic solution, and serial dilutions were
plated on mannitol salt agar. Results are expressed as means±SEM of
three independent experiments performed in duplicate.
Cytotoxicity assay. Prior to infection, HUVECs were washed with
EGM-2 medium without antibiotics, and a total of 107 S. aureus were
added per well (m.o.i. 50). Determination of the m.o.i. was based on
our pilot study and a previous study (Krut et al., 2003). After 1 h, the
HUVECs were washed with antibiotic-free EGM-2 medium and
incubated at 37 uC for 24 h with 10 mg lysostaphin ml21. The
supernatants of the infected cultures were then carefully removed to
preserve any detached cells, and adherent cells were harvested by
standard trypsin treatment and combined with the supernatants. Viable
cells were then counted by the trypan blue (Sigma) exclusion method
(Bonifacio, 2000), and cytotoxicity was expressed as the percentage of
dead cells. Three independent experiments were performed.
Statistical analysis. The Mann–Whitney U test and Fisher’s exact
test were used for comparison of continuous and categorical variables,
respectively. P ,0.05 was considered to be statistically significant.
Statistical analysis was carried out using the SPSS software package.
RESULTS
Patients and clinical isolates
Fifty-one patients with community-acquired S. aureus
bacteraemia were identified during the study period.
Among these were 11 (22 %) cases of metastatic infection.
Metastatic foci included cardiac valve, bone and joint, lung,
central nervous system, and abdominal organs (Table 1).
Eleven patients were selected as the control group, as
described in Methods. The median age was 55.5 years (range
24–70) in the case group and 51 years (range 23–76) in the
control group (P50.70). Sixty per cent of the case patients
and 55 % of the control patients were male (P51.00). The
portal of entry was not identified in nine (82 %) of the
patients with metastatic infection and in two (18 %) of the
patients without metastatic infection (P50.01). An isolate
from one patient in the case group was not available;
therefore, 10 isolates from the case group and 11 from the
control group were used in this study. All were meticillin-
susceptible and PFGE did not show any evidence of outbreak
in the community. Five patients in the case group and four in
the control group were treated with anti-staphylococcal
penicillin, and five patients in the case group and seven in the
control group were treated with cephalosporin (P50.67).
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Invasion assay
The clinical S. aureus isolates varied in their ability to
invade endothelial cells (Fig. 1). The median invasiveness,
relative to the reference strain ATCC 29213, was 145 %
[interquartile range (IQR) 103–160] in the cases with
metastatic infection and 153 % (IQR 111–173) in the
control patients without metastatic infection (Fig. 1).
There was no significant difference in invasiveness between
the case and control patients (P50.44).
Cytotoxicity assay
The cytotoxic activity of the clinical isolates varied
considerably (Fig. 2). The median cytotoxicity was 59 %
(IQR 47–68) in the case group and 65 % (IQR 50–74) in
the control group. No statistically significant differences
between the two groups were observed (P50.44).
The isolates from the patients without metastatic infection
were also isolated from blood culture; therefore, they may
have been more virulent than the colonizers from healthy
carriers. We therefore performed cytotoxicity assays with
an additional 10 isolates from healthy carriers. Colonizers
from the healthy carriers had a median cytotoxicity of 55 %
(IQR 51–70), which was not statistically different from that
of the clinical isolates (P50.87).
DISCUSSION
We demonstrated that although the clinical S. aureus
isolates varied widely in their ability to invade endothelial
cells, the isolates from patients with simple bacteraemia
Table 1. Basal characteristics and site of infection in the S. aureus bacteraemic patients with or
without metastatic infection
CRI, Catheter-related infection; IE, infective endocarditis; STI, soft tissue infection; CNS, central nervous
system; PTBD, percutaneous biliary drainage.
Bacteraemia with metastasis Simple bacteraemia
Age (years) Sex Portal of entry Metastatic foci Age (years) Sex Portal of entry
24 M CRI Abdominal organ 23 F Pneumonia
34 F Unknown IE, lung 34 M STI
51 F Unknown CNS 36 F STI
51 F Unknown Osteomyelitis 43 M Unknown
55 M STI Lung 47 F CRI
56 M Unknown IE, CNS, abdominal
organ
51 F PTBD cholangitis
56 M Unknown IE, CNS 58 M STI
59* M Unknown Lung 60 F Unknown
64 M Unknown IE, CNS 62 M Wound infection
69 M Unknown Osteomyelitis 68 M STI
70 F Unknown Psoas abscess 76 M Pneumonia
*An isolate from this patient was not available.
Fig. 1. Invasiveness of S. aureus clinical isolates from patients
with or without metastatic infection (MI). The results are
means±SEM of three independent experiments, expressed as
invasiveness relative to strain ATCC 29213. Solid horizontal lines
indicate the mean invasiveness of each group; dotted horizontal
lines indicate the median invasiveness of each group.
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were as invasive as those from patients with metastatic
complications. Since the bacteria must exit the infected
cells and enter the subendothelial space in order to
disseminate infection to other tissues, we also compared
the cytotoxicity of the internalized S. aureus. Again, isolates
from the patients without metastatic infection had equal
ability to those from metastatic infections to kill the
endothelial cells after internalization. Furthermore, colo-
nizers from healthy carriers displayed similar cytotoxicity.
These data strongly suggest that some factor(s) other than
those that permit the organism to invade and kill endothelial
cells is needed for the development of a metastatic infection.
Possibly, S. aureus contains either a molecule permitting
adhesion to specific tissue sites (Marriott et al., 2005) or a
toxin that can cause tissue injury (Fowler et al., 2005), or
possesses a mechanism for evading the host immune system
(Lowy, 1998). It is also possible that S. aureus extravasates
via the intercellular space. Palmqvist et al. (2005) have
shown that a gene knockout of S. aureus LS-1 which lacks
fibronectin-binding protein gives rise to spontaneous
arthritis, despite the fact that the fibronectin-binding
protein is indispensable for invasion of endothelial cells
(Peacock et al., 1999). It seems likely, therefore, that
metastatic infection can develop without direct invasion of
vascular endothelial cells. We suggest that host factors or
host–pathogen interactions may be more important for the
development of metastatic infection than are strictly
microbial factors, because in a mouse bacteraemia model,
we did not detect any difference in dissemination to internal
organs in clinical isolates from patients with and without
metastatic infection (data not shown).
Host factors that increase rates of metastatic seeding during
S. aureus bacteraemia include: (1) an unknown primary
focus; (2) community acquisition; and (3) S. aureus
bacteraemia not associated with removable foci
(Lautenschlager et al., 1993; Finkelstein et al., 1984;
Hedstrom & Christensson, 1983; Fowler et al., 2005). The
present study also revealed an association between patients
with metastatic infection and unknown primary focus.
Perhaps S. aureus specifically responsible for community-
acquired infection may have an unknown virulence factor
that facilitates metastatic infection, given that patients from
the community display relatively intact immunity in the
usual clinical setting. Alternatively, community-acquired
bacteraemia may be associated with persistent bacteraemia.
The above-cited clinical studies support the hypothesis that
bacteraemia of long duration is linked to metastatic
infection. However, in this study, we were unable to
examine this factor because the duration of bacteraemia
prior to admission could not be established.
We confined the study population to patients with
community-acquired S. aureus bacteraemia because: (1)
patients with nosocomial S. aureus bacteraemia usually
have severe immune defects that override other pathogenic
virulence factors in the development of metastatic
infection; and (2) community-acquired S. aureus may
possess as-yet-unknown virulence factors that can promote
the invasion of vascular endothelial cells.
The variable frequency of metastatic infection in earlier
studies may have been due to variation in the methods of
detection; for instance, the use of echocardiography to
detect endocarditis in some cases (Ringberg et al., 2000). In
Fig. 2. Cytotoxicity of S. aureus isolates from patients with and without metastatic infection (MI). The percentage cell death was
measured 24 h after infection. The results are expressed as the means±SEM of three independent experiments. Control
denotes the percentage of dead cells in cultures not exposed to any bacteria. Solid horizontal lines indicate the mean
cytotoxicity of each group; dotted horizontal lines indicate the median cytotoxicity of each group.
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the present study, to minimize the possibility of over-
looking subclinical metastatic infection in the control
group, we excluded those patients whose fever lasted .3
days after the initiation of antibiotic treatment, because a
delay in response suggests the existence of undetected
metastatic foci.
There are many methods for counting intracellular organ-
isms, such as fluorescence assays and direct visual methods
(Beekhuizen et al., 1997; Krut et al., 2003). In the present
study, we chose the approach of plating and colony counting
because it yields numbers of live organisms, and dead or
dying organisms do not cause metastatic infection.
This study has several limitations. First of all, conditions of
flow in vivo may influence the interaction of S. aureus with
vascular endothelial cells, and endothelial receptors may
show differential adhesion under shear flow conditions, with
rolling and static receptors (McCormick et al., 1997). With
respect to in vitro experiments and in vivo infection, there
may be marked differences in expression of genes associated
with virulence, such as that encoding fibronectin-binding
protein, a major mediator of non-professional phagocyte
invasion (Menzies, 2003). Finally, the number of clinical
strains used in this study may not be sufficient to detect any
subtle differences between each group. To prove the
difference of invasiveness in 80 % power and 0.05 alpha
error, the isolates from the case group should have been
.30 % more invasive than those from the control group.
In summary, clinical S. aureus isolates from patients with
simple bacteraemia were as effective at invasion of vascular
endothelial cells and induction of cell death as were isolates
from patients with metastatic infection. This finding suggests
the importance of host factors or as-yet-unidentified
virulence factors other than invasiveness or cytotoxicity of
S. aureus for vascular endothelial cells, which result in metas-
tatic complications in patients with S. aureus bacteraemia.
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